Targeted Disruption of Endothelial Cell-selective Adhesion Molecule Inhibits Angiogenic Processes in Vitro and in Vivo
Open Access
- 1 September 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (36) , 34598-34604
- https://doi.org/10.1074/jbc.m304890200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growthBlood, 2003
- A Transmembrane Tight Junction Protein Selectively Expressed on Endothelial Cells and PlateletsJournal of Biological Chemistry, 2002
- Cloning of Human Junctional Adhesion Molecule 3 (JAM3) and Its Identification as the JAM2 Counter-receptorPublished by Elsevier ,2001
- JAM-2, a Novel Immunoglobulin Superfamily Molecule, Expressed by Endothelial and Lymphatic CellsJournal of Biological Chemistry, 2001
- A Novel Protein with Homology to the Junctional Adhesion MoleculeJournal of Biological Chemistry, 2000
- Vascular Endothelial Junction-associated Molecule, a Novel Member of the Immunoglobulin Superfamily, Is Localized to Intercellular Boundaries of Endothelial CellsPublished by Elsevier ,2000
- Mechanisms of angiogenesisNature, 1997
- The biology of PECAM-1.Journal of Clinical Investigation, 1997
- S‐Endo 1, a pan‐endothelial monoclonal antibody recognizing a novel human endothelial antigenTissue Antigens, 1996
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990